Summary In 2007, Medicare Australia revised reimbursement guidelines for dual energy X-ray absorptiometry (DXA) for Australians aged ≥70 years; we examined whether these changes increased DXA referrals in older adults. Proportions of DXA referrals doubled for men and tripled for women from 2003 to 2010; however, rates of utilization remained low. Introduction On April 1, 2007 Medicare Australia revised reimbursement guidelines for DXA for Australians aged ≥70 year; changes that were intended to increase the proportion of older adults being tested. We examined whether changes to reimbursement increased DXA referrals in older adults, and whether any sex differences in referrals were observed in the Barwon Statistical Division.
Introduction
Osteoporosis is a systemic skeletal disease characterized by low bone mineral density (BMD) and micro-architectural deterioration of bone tissue with a consequent increase in susceptibility to fracture [1] . BMD is a surrogate for bone strength, and a reduction in BMD is associated with an increased fracture risk [1, 2] . Fragility fractures at the spine, hip, forearm, and proximal humerus are a major public health problem for both sexes and annually cost the Australian community $1.9 billion in direct costs and $7.4 billion when indirect costs are also considered [3] . The short-and long-term impact of fracture on mobility and lifestyle may be extensive and may also depend on the fracture site mediated by frailty and other comorbidities [4] . Furthermore, there is an increased likelihood of morbidity and mortality following hip fracture, especially in elderly persons [5] . In Australia, hip fractures have been predicted to increase from 15.2 thousand per year in 1996 to 33.9 thousand per year by 2025 rising to 60,000 per year in 2051 [6] . Although recent data show that hip fracture rates are declining over time [7] , nevertheless, fracture risk continues to increase by 3 % for every year of age [2] . This increasing burden of chronic disease is a critical issue facing Australia's health system and will increase in absolute terms due to our aging population [6, 8] unless greater effort is put into effective management and prevention.
Measurement of BMD using dual energy X-ray absorptiometry (DXA) is currently one of the key strategies to identify low BMD, and thus, inform the decision making regarding anti-fracture treatment to reduce the burden of fracture [9, 10] . There is a sturdy body of evidence indicating strong associations between osteoporotic fractures and low BMD, including BMD within the low or osteopenic range [2] . Data indicate that the risk of fracture is increased approximately 1.5-fold for every one standard decrease in BMD for men and women [11] . Furthermore, individuals are more likely to be treated for osteoporosis following a bone density scan, measured by DXA [1] , and treatment programs following prior DXA are far more cost-effective than those where a prior scan was not performed [12] .
Bone loss in men is often overshadowed by its effects in women, although men also incur substantial bone loss with aging [13, 14] . One in three men develops osteoporosis compared with one in two women; however, mortality risk is greater among men following hip fracture compared to women [15] . Men are believed to be more likely to have osteoporosis due to secondary causes, for instance hypogonadism [16] , and decreases in total and free testosterone levels are associated with aging [17] . Importantly, research suggests that non-treatment in men remains a concern [18] , a phenomenon seen in many countries.
On April 1, 2007, changes to national health policy were introduced Australia wide in order to increase the utilization of DXA in men and women aged 70 years and older in efforts to delay or avoid incident fractures. In the context of patient care, that policy change paved the way for equal access (pending referral) to DXA between sexes and reduced out-of-pocket expenses for the patient. To date, the impact of those changes remains unknown. Thus, the aim of this study is to examine the impact of reimbursement for DXA introduced by Medicare Australia in 2007 for men and women aged 70 years and older. 
Methods

Subjects
Statistical analysis
Absolute numbers of those referred to DXA during the period 2003-2010 were stratified by 5-year age groups, sex, and year of referral. Referral rates for men and women were calculated based on the population at risk for each year using annual population-specific data from the Australian Bureau of Statistics Census data [19] , and rate ratios between the sexes were calculated. Referral rates for men and women in each 5-year age group were calculated separately 
Results
Overall, 6,096 individuals (21.2 % men) were referred for DXA in the age range of interest during the 8-year study period. Table 1 shows that the proportions of DXA referrals increased from 2003 to 2010 for both sexes; for men, there was a doubling of proportions from 0.8 to 1.8 %, whereas for women, the proportions tripled from 2.0 to a Population aged 70 years and older resident in the Barwon Statistical Division, population-specific data for each year ascertained from the Australian Bureau of Statistics [19] was 
Discussion
We observed a doubling of proportions of men and a tripling of women referred to DXA from 2003 to 2010. Given the increase in DXA referrals observed in both sexes that was occurring before the 2007 introduction of reimbursement by Medicare Australia, we speculate that the change in policy is unlikely to have influenced the increase in DXA referrals observed post-2007 in the BSD. Importantly, the utilization of DXA testing in older individuals remained very low despite the nationwide availability of reimbursement for testing in this high-risk group. Furthermore, women were commonly three times more likely than men to be referred for a DXA test during the 8-year study period. In order to examine the impact of DXA reimbursement on the most at risk population at whom the policy was directed, there is a need for summary measures to assist in elucidating the different dimensions that may influence the impact [20] . To evaluate reimbursement for DXA, we must be able to determine whether interventions had an impact, whether the impact was sufficient and equitable across groups, and whether those changes are sustainable in the real-world setting. For purposes such as this, the Reach, Efficacy, Adoption, Implementation, and Maintenance (RE-AIM) framework provides a useful tool to assess five dimensions of policy implementation or change [21, 22] ; it is a framework often used to assess the public health impact of policies [22] and is suggested as appropriate within the necessary recurring process of policy evaluation [23] .
The first dimension of RE-AIM is "Reach," a dimension that is concerned with the percentage and characteristics of individuals affected by the policy, and therefore, assesses how the policy has differentially impacted on the target population. In this context, Reach examines the extent to which older Australians aged 70 years and older are referred to DXA and undergo the testing [21, 22] . The small proportion (3.1 %) of individuals aged 70 years and older who underwent DXA testing by the end of 2010 reflects a limited reach of this policy change in the BSD. To increase the reach of this policy, it should be considered whether broadening the reach of care would be a suitable amendment to current policy and whether targeting practitioners would increase the proportion of the overall population being tested. Given that we observed no difference in the sex distribution post-policy change, it is plausible that men were either not sufficiently reached or perhaps not willing or uncomprehending of the need to follow-up the referral with the DXA service provider. However, the limited number of DXA providers in the BSD may further influence the reach of this policy, resulting in lower testing than ideal in both sexes. Although recommendations regarding the ideal ratio of DXA machines to population numbers do not exist, European data that predate the development of FRAX tools suggested the requirements for DXA in assessment varied between 4.21 and 11.21 units per million persons, and when clinical risk factors were considered with the selective use of BMD, 10.6 units per million would be needed to monitor treatment [24] . With a BSD population of approximately 250,000 and two clinical DXAs at the Geelong Bone Density Service, we would be included in the lower to middle range of estimated DXA requirements. Given that approximately 20 % of the BSD population resides at some distance from the service, this may limit access to some extent.
"Effectiveness" is the second dimension of RE-AIM, an aspect concerned with describing the impact of an intervention or policy [21, 22] . The underlying premise to reimburse DXA for Australians aged 70 years and older was to identify fracture risk in a high-risk group and where osteoporosis was identified to monitor or treat the individual, thereby reducing incident fracture and the associated morbidity and mortality. Undergoing DXA increases the level of information a practitioner has at hand, and thus, may theoretically increase the likelihood that treatment may be initiated for pre-or postfracture care, where such a need was warranted. To date, the policy change introduced by Medicare Australia seems to have had limited effectiveness in reaching those at greatest risk of fracture-Australian men and women aged 70 years and older. Limited effectiveness will result in sustained, and possibly increased, public health expenditure on incident fractures. Whilst osteoporosis is more common in women, men have excess morbidity and mortality post-fracture compared with women [25, 26] , and thus, it is imperative that neither sex remains untreated where risk is identified.
"Adoption," the third dimension of RE-AIM, occurs at the organizational level and considers whether policy execution occurred as intended [21, 22] . The adoption of changes to policy may be thwarted by barriers including organizational impediments to inter-and intra-agency collaboration and service delivery, political debates, or competing concerns related to the provision of health care. Given that the doubling of proportions observed for undergoing a DXA test post-April 1, 2007 compared to pre-April 1, 2007 was similar to the linear increase observed in DXA referrals before 2007, it is plausible that changes to Medicare Australia reimbursement policy may have had little impact on physician behaviors in referral practices. Importantly, underdiagnosis in both sexes remains a problem. However, taking into consideration the expected lag between policy change and practices, it is possible that the largest proportion of DXA referrals seen in 2010 (1.8 % for men and 6.3 % for women) could be a reflection of increased adoption. Given that possibility, it is imperative that ongoing evaluation of this policy be conducted to determine whether significant increases in DXA utilization are seen post-2010, as these proportions of DXA utilization in the population at highest risk is highly unlikely to have much impact on reducing fracture risk.
The fourth dimension "Implementation" assesses the consistency with which the policy was delivered as intended at the organizational level, also referred to as the internal validity [21, 22] . The policy decree that saw changes to DXA reimbursement suggests that the implementation should have occurred automatically. However, whilst those who did undergo a DXA were reimbursed according to policy, the actual changes to policy did not influence consistency in referral to DXA for osteoporosis; our data show a consistently low uptake of DXA in the target population group. Whether it is the practitioner who fails to refer or the patient who fails to undergo DXA despite referral and potential benefits, the low rate of DXA utilization for both sexes in this high-risk age group remains a public health concern.
"Maintenance" in the RE-AIM framework assesses the potential for long-term sustainability, an issue determined by the extent that the policy becomes encompassed in routine organizational practice and individual behavior [21, 22] . Given that the maintenance of a policy hinges on its adoption over the ensuing years [22] , we examined a 6-year period following the introduction of this policy change. However, this analysis suggests that in the BSD, the impact on DXA uptake in older Australians as a result of changes to Medicare Australia reimbursement has been minor. Importantly, the low impact of this policy to date may be related to a combination of the interdependent dimensions considered within the RE-AIM framework rather than one dimension alone.
Use of the RE-AIM framework enables an evaluative reflection on the five dimensions of successful policy implementation and identification of areas where further work is needed. For example, we speculate that a targeted approach is required to increase the utilization of DXA subsidization for those groups at most risk of undertreatment for fracture, specifically men. These approaches could include increased efforts from practitioners to employ equitable referral practices to DXA testing, raising population health literacy to increase the likelihood of initiating a DXA test and further evaluation of health policy changes on a cyclical basis to evaluate impact and thus inform policy makers in efforts to enhance care. Furthermore, it is important to examine whether the low utilization of DXA is influenced by practitioner referrals and potentially their own beliefs about the salience of osteoporosis [27] , patient unwillingness, or a combination. Further evaluation regarding the impact over time of DXA reimbursement can only enhance the original goals of the health policy-that is to reduce the likelihood of a first or subsequent fracture in our older Australians.
This study has some strengths. First, the BSD is an excellent base for epidemiological research because there are clear geographic boundaries, a mixture of rural and urban populations, a representative range of multicultural groups, and one centralized public health provider located at the hub of the region in Geelong. These are the first data to examine whether health policy changes regarding reimbursement increased the referral to DXA testing in the elderly. Our data span an 8-year period, enabling us to examine 4 years of data pre-and post-2007, the year in which changes to reimbursement policy were introduced by Medicare Australia. Our study also has some limitations. Some individuals may have undergone a DXA scan in an alternative geographical region resulting in missing health service utilization data and therefore potentially underreported data. We examined DXA utilization provided by the major service provider for the BSD region, and thus, data pertaining to persons who had undergone a DXA at the smaller private health service provider would not have been included. However, we have previously estimated that only 5 % of required DXA services for the BSD would not be provided by the Geelong Bone Density Service [28] . We were unable to examine the role played by ethnicity in the uptake of DXA testing, although acknowledge the role that this important factor may play [29] .
Despite public health awareness campaigns, low uptake and a sex bias in bone densitometry presents major public health challenges, indicating the need to correct the balance between health policies and predisposing factors which influence referral practices and patient initiation of testing. These data provide a conceptual advance in our knowledge regarding the referral of older adults to DXA testing for preventive health care related to osteoporosis and osteoporotic fracture, which is critical from a preventive and treatment standpoint but also from an economic and public health perspective. Furthermore, these data provide a better understanding of the impact of policy changes introduced by Medicare Australia; the overall low referral rate to DXA indicates a concerning situation that is likely to impact upon the burden of chronic disease, especially for men.
